MEDP

Medpace Holdings Inc.

Price

$583.08

return (12m)

35.98%

p/e

32.46

p/bv

36.77

DIVIDEND YIELD

0.00%

MEDP price

Medpace Holdings

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MEDP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

8.78%

3 months

37.52%

1 year

35.98%

2 years

58.48%

5 years

227.77%

10 years

0.00%

Fundamentals MEDP

Valuation

P/E

32.46

Sector -3.98

Industry -3.98

P/BV

36.77

Sector 1.99

Industry 1.99

P/Revenue (PSR)

5.73

Sector -4.41

Industry -4.41

EV/EBITDA

100.63

Sector -245.01

Industry -245.01

EV/EBIT

105.23

Sector -666.51

Industry -666.51

P/EBITDA

26.10

Sector -4.07

Industry -4.07

P/EBIT

27.34

Sector -4.24

Industry -4.24

P/Total Assets

7.75

Sector 1.41

Industry 1.41

P/Net Current Assets

-27.84

Sector -11.63

Industry -11.63

P/Working Capital

-41.42

Sector -11.07

Industry -11.07

EPS

17.55

Sector -2.20

Industry -2.20

BVPS

15.50

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

28.76%

Sector 36.05%

Industry 36.05%

EBITDA Margin

21.71%

Sector -16,817.20%

Industry -16,817.20%

EBIT Margin

20.76%

Sector -4,256,841.62%

Industry -4,256,841.62%

Operating Margin

20.97%

Sector -38.74%

Industry -38.74%

Net Profit Margins

17.67%

Sector -39.50%

Industry -39.50%

Asset Turnover

0.34

Sector 0.03

Industry 0.03

Profitability

ROE

113.29%

Sector -65.98%

Industry -65.98%

ROA

23.89%

Sector -66.05%

Industry -66.05%

ROIC

23.56%

Sector -1,703.97%

Industry -1,703.97%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

0.73

Sector 2.89

Industry 2.89

Net Debt / EBITDA

-3.27

Sector 1.92

Industry 1.92

Net Debt / EBIT

-3.42

Sector -7.14

Industry -7.14

Net Debt / Equity

-1.16

Sector -33,112.90

Industry -33,112.90

Gross Debt / Equity

0.00

Sector -0.02

Industry -0.02

Equity/Assets

0.21

Sector 0.42

Industry 0.42

Liabilities/Assets

0.79

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

19.49%

Sector -

Industry -

5Y Earnings CAGR

22.00%

Sector -

Industry -

FAIR VALUE OF Medpace Holdings ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$583.08

Fair Value

$78.23

Upside Return potential.

-86.58%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals MEDP

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
MEDP	32.46	36.77	113.29%	0.00%	$15.95 B	17.67%
JNJ	29.40	7.28	24.76%	2.04%	$618.44 B	21.48%
PFE	18.75	1.55	8.29%	6.97%	$140.44 B	11.83%
ABBV	68.57	-73.49	-107.17%	2.76%	$432.69 B	9.80%
NVO	11.00	6.65	60.40%	3.96%	$208.75 B	37.15%
MRK	35.97	7.00	19.45%	2.58%	$321.35 B	13.59%
AZN	25.16	5.22	20.74%	1.89%	$262.79 B	17.02%
GILD	17.55	6.90	39.33%	2.47%	$161.73 B	30.99%
BMY	14.12	5.87	41.59%	3.91%	$131.06 B	18.87%
ZTS	12.23	10.00	81.75%	2.69%	$32.33 B	27.79%
REGN	17.58	2.40	13.65%	0.49%	$76.11 B	27.86%
AMGN	26.41	22.42	84.87%	2.57%	$206.02 B	20.96%
HALO	27.82	44.19	158.82%	0.00%	$9.70 B	23.13%
MCK	22.00	-125.59	-570.98%	0.38%	$104.74 B	1.18%
VRTX	27.75	6.22	22.41%	0.00%	$120.39 B	35.51%
CAH	34.61	-20.14	-58.20%	0.89%	$53.82 B	0.62%
HRMY	13.88	2.22	16.00%	0.00%	$2.02 B	16.20%
BIIB	36.30	1.61	4.43%	0.00%	$30.30 B	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MEDP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Medpace Holdings

Medpace Holdings Inc.

Average Investor10 user rating

4.0 (16 people)

United States

12 years

Founded: 2014

2016

Time since IPO - 10 years

3.500

Employees

Medpace Holdings Inc. (United States) is listed on the Nasdaq and has a market capitalization of $15.95 billion, with shareholders equity totaling $433.86 million.

The company employs approximately 3.500 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Medpace Holdings Inc. reported $2.78 billion in revenue, generating net income of $491.50 million.

Key financial metrics include a P/E ratio of 32.46, a price-to-book (P/B) ratio of 36.77, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MEDP.

Market cap

$15.95 billion

Net worth

$433.86 million

$433,860,000.00

Assets

$2.06 billion

$2,057,180,000.00

Total Shares Outstanding

28.00 million

28,000,000

Average Daily Trading Volume

$344.68 Thousand

$344,676.00

Sector

Health Care

Industry

Biotechnology

MEDP

MEDP revenue and profits

Financial Results MEDP

DRAG THE FRAME TO SEE MORE DATA

MEDP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$881.98 32,60% (12M)

P/E

22.00

0.38%

ROE

-570.98%

P/BV

-125.59

CAH - Cardinal Health

$238.75 53,27% (12M)

P/E

34.61

0.89%

ROE

-58.20%

P/BV

-20.14

JNJ - Johnson & Johnson

$256.80 52,65% (12M)

P/E

29.40

2.04%

ROE

24.76%

P/BV

7.28

ABBV - AbbVie

$244.60 28,54% (12M)

P/E

68.57

2.76%

ROE

-107.17%

P/BV

-73.49

MRK - Merck & Co.

$128.41 65,49% (12M)

P/E

35.97

2.58%

ROE

19.45%

P/BV

7.00

AZN - AstraZeneca

$160.68 11,06% (12M)

P/E

25.16

1.89%

ROE

20.74%

P/BV

5.22

NVO - Novo Nordisk

$47.02 --1,17% (12M)

P/E

11.00

3.96%

ROE

60.40%

P/BV

6.65

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$881.98 32,60% (12 M)

P/L

22.00

0.38%

ROE

-570.98%

P/VP

-125.59

CAH - Cardinal Health

$238.75 53,27% (12 M)

P/L

34.61

0.89%

ROE

-58.20%

P/VP

-20.14

JNJ - Johnson & Johnson

$256.80 52,65% (12 M)

P/L

29.40

2.04%

ROE

24.76%

P/VP

7.28

ABBV - AbbVie

$244.60 28,54% (12 M)

P/L

68.57

2.76%

ROE

-107.17%

P/VP

-73.49

MRK - Merck & Co.

$128.41 65,49% (12 M)

P/L

35.97

2.58%

ROE

19.45%

P/VP

7.00

AZN - AstraZeneca

$160.68 11,06% (12 M)

P/L

25.16

1.89%

ROE

20.74%

P/VP

5.22

NVO - Novo Nordisk

$47.02 --1,17% (12 M)

P/L

11.00

3.96%

ROE

60.40%

P/VP

6.65

Frequently Asked Questions

What is the price of Medpace Holdings (MEDP) today?

A cotação de Medpace Holdings (MEDP) hoje está em US$ 583.08, com uma variação de 35.98% em relação ao último ano. A cotação de Medpace Holdings (MEDP) iniciou o ano negociando na casa dos US$ 561.65 e hoje está em US$ 583.08. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Medpace Holdings (MEDP) e dados de ações do Ibovespa e mercados internacionais.

Quando Medpace Holdings (MEDP) paga dividendos?

Medpace Holdings (MEDP) não distribuiu dividendos no último ano.

Is Medpace Holdings (MEDP) a good investment?

Atualmente, Medpace Holdings (MEDP) está cotada a US$ 583.08, com um P/L de 32.46, representando um desvio de 3,075% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 35.98 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 35.98%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Medpace Holdings (MEDP) stock?

Investir em ações de Medpace Holdings (MEDP) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Medpace Holdings (MEDP) yield today?

A rentabilidade de Medpace Holdings (MEDP) foi de 8.78% no último mês, 35.98% no último ano e 227.77% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Medpace Holdings (MEDP) hoje, o investimento total seria de US$ 58,307.50, com base na cotação atual de US$ 583.08.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 79,286.54
Em 5 anos: US$ 191,114.49
Em 10 anos: US$ 58,307.50

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MEDP

Medpace Holdings Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MEDP

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Medpace Holdings

Medpace Holdings Inc.

United States

12 years

2016

3.500

PROFIT X PRICE MEDP

Financial Results MEDP

MEDP cash flow

Asset, Revenue and Profit Growth - MEDP

MEDP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

Frequently Asked Questions